Harnessing AI for Breakthrough Innovation and Strategic Impact from Regulatory Function
Wednesday, October 16th, 12:00 - 1:00 PM PT
Register Now for the Free Webinar
In today’s rapidly evolving technical landscape, artificial intelligence (AI) has emerged as a transformative force across industries. However, AI’s potential to revolutionize regulatory functions and drive strategic innovation remains largely untapped, especially in the life science industry.
Join our webinar to explore how organizations can leverage AI to streamline compliance processes, uncover new opportunities, mitigate risks, and gain a competitive edge over competitors.
Webinar Overview
Topics Covered:
Fundamentals of AI:
Difference between traditional AI and generative AI.
Use cases in life sciences across the product life cycle.
AI Integration in Life Sciences:
Incorporating AI into workflows for enhanced functionality.
How to get your organization AI-ready.
Harnessing AI for Transformation of Regulatory Affairs:
AI's potential to revolutionize regulatory teams by automating routine tasks.
Dos and Don’ts for using AI in regulatory affairs
Who Should Attend?
Professionals working in life sciences and healthcare industries
Researchers and innovators exploring AI applications in healthcare
Executives and decision-makers interested in AI-driven innovation
Michelle Wu is the founder and CEO of NyquistAI. She has over a decade of experience in pharmaceuticals, medical technology, and digital innovation. Before founding NyquistAI, she was the youngest global strategy manager at Novartis AG where she worked on the very first and so far the only asset swap deal in the history of the pharmaceutical industry among Novartis, Eli Lilly, and GSK, which led her to realize the universal pain point of manual and cumbersome data research and potential pitfalls if it is not done right. This experience inspired her to build NyquistAI. Prior to Novartis, she worked for the life science practice for BCG and served big innovative pharmaceutical and Medtech companies on their global strategy, product development strategy, and emerging market strategies. She received her MBA from Stanford University and BA from Peking University. She speaks English, Chinese, Vietnamese, Japanese, and a bit of German given her global work experience in Asia, Europe, and now the US.
